Union Budget 2026: Rs 10,000-cr 'Biopharma Shakti' to Boost Biologics Manufacturing
News
F
Firstpost•01-02-2026, 11:33
Union Budget 2026: Rs 10,000-cr 'Biopharma Shakti' to Boost Biologics Manufacturing
- •Finance Minister Nirmala Sitharaman announced 'Biopharma Shakti' in Union Budget 2026.
- •The program is a ₹10,000-crore strategy to strengthen India’s biologics ecosystem.
- •It aims to position India as a global biopharmaceutical manufacturing hub.
- •The five-year initiative focuses on building domestic capabilities in biologics and biosimilars.
- •This is crucial as India's disease burden shifts towards non-communicable illnesses like diabetes, cancer, and autoimmune disorders.
Why It Matters: Union Budget 2026 introduces 'Biopharma Shakti' with ₹10,000-cr to boost India's biologics manufacturing.
✦
More like this
Loading more articles...
